Global Pharmaceuticals & Biotech Profitable Climbers

Corcept Therapeutics

Market Cap: US$9.7b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Jiangxi Fushine Pharmaceutical

Market Cap: CN¥9.2b

Engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$51.1b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Rubicon Research

Market Cap: ₹237.2b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Camurus

Market Cap: SEK 37.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 13.2b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Kuros Biosciences

Market Cap: CHF 818.4m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Neuren Pharmaceuticals

Market Cap: AU$2.1b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

PharmaEssentia

Market Cap: NT$492.6b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

BioArctic

Market Cap: SEK 26.6b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Krystal Biotech

Market Cap: US$10.5b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Wedge IndustrialLtd

Market Cap: CN¥11.6b

Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.

Acutaas Chemicals

Market Cap: ₹296.3b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

WuXi XDC Cayman

Market Cap: HK$67.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Aether Industries

Market Cap: ₹195.8b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Royalty Pharma

Market Cap: US$33.5b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

SKAN Group

Market Cap: CHF 1.3b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Sakar Healthcare

Market Cap: ₹19.5b

Research, develops, manufactures, and sells pharmaceutical products in India.

PharmaResources (Shanghai)

Market Cap: CN¥5.1b

Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.

Abeona Therapeutics

Market Cap: US$399.0m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Zevra Therapeutics

Market Cap: US$754.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Novogenia

Market Cap: €78.0m

Manufactures and sells personalized health products in global markets.

Shanghai Haoyuan Chemexpress

Market Cap: CN¥15.1b

Engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs.

Alnylam Pharmaceuticals

Market Cap: US$35.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

XtalPi Holdings

Market Cap: HK$30.9b

Operates as a research platform company in Mainland China, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$50.4b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$4.9b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

CORONA Remedies

Market Cap: ₹126.1b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

Labiana Health

Market Cap: €52.7m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.

Apotex Health

Market Cap: CA$8.6b

Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Senores Pharmaceuticals

Market Cap: ₹64.7b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

SIGA Technologies

Market Cap: US$246.7m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

argenx

Market Cap: €47.0b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Cantourage Group

Market Cap: €66.6m

Operates as a medical cannabis company in Europe and internationally.